Topics
News
CME/CE
Editorial Advisory Board
Partners
Subscribe
- Case-Based Roundtable
- General Dermatology
- Eczema
- Chronic Hand Eczema
- Alopecia
- Aesthetics
- Vitiligo
- COVID-19
- Actinic Keratosis
- Precision Medicine and Biologics
- Rare Disease
- Wound Care
- Rosacea
- Psoriasis
- Psoriatic Arthritis
- Atopic Dermatitis
- Melasma
- NP and PA
- Skin Cancer
- Hidradenitis Suppurativa
- Drug Watch
- Pigmentary Disorders
- Acne
- Pediatric Dermatology
- Practice Management
- Prurigo Nodularis
- Buy-and-Bill
Opinion
Video
Differentiating Clinical Markers in Vitiligo: Managing Unstable Disease and Depigmented Macules
Author(s):
An expert on vitiligo discusses the case of a 49-year-old woman with a history of vitiligo who presents with depigmented macules on her abdomen, thighs, and forearms that developed over 2 months.
Video content above is prompted by the following questions:
- What is your impression of this case?
- What challenges does this case present with, if any?
- What considerations should be taken into account when treating a patient with worsening vitiligo involving large BSA?
- In your clinical practice, what role does the amount of BSA coverage play in your treatment decisions?
- Are there BSA limits you adhere to when treating patients with widespread vitiligo?
- What is your approach to the patient with worsening vitiligo that involves high BSA?
Related Videos
Related Content
